Medtronic PLC (LTS:0Y6X)
$ 81.63 1.13 (1.41%) Market Cap: 104.56 Bil Enterprise Value: 125.12 Bil PE Ratio: 25.24 PB Ratio: 2.18 GF Score: 78/100

Medtronic PLC Investor Briefing at North American Neuromodulation Society Annual Meeting Transcript

Jan 24, 2020 / 04:30PM GMT
Release Date Price: $120.97 (+0.33%)
Ryan Weispfenning
Medtronic plc - VP of IR

Okay. Good morning, everyone. Good morning. We're going to get started here. So let's see, we'll get the slide advanced here. Here we go.

I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thanks for coming to our Restorative Therapies Group Investor Briefing here at the North American Neuromodulation Society conference here in Las Vegas, and welcome to those joining us around the world on our webcast.

Before we get started, I want to note that we could make some comments that may be considered forward-looking statements, and actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement.

I encourage you to go back and read this slide. The slides we're presenting today, they are available on our website, which is investorrelations.medtronic.com.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot